ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $576,842 | -31.6% | 22,577 | -23.2% | 0.00% | 0.0% |
| Q2 2023 | $842,934 | +10.4% | 29,391 | -7.7% | 0.00% | 0.0% |
| Q1 2023 | $763,492 | +78.6% | 31,852 | +26.4% | 0.00% | 0.0% |
| Q4 2022 | $427,460 | -100.0% | 25,204 | -58.2% | 0.00% | 0.0% |
| Q3 2022 | $894,431,000 | +1026.8% | 60,353 | +1096.8% | 0.00% | – |
| Q2 2022 | $79,377,000 | -4.6% | 5,043 | +63.4% | 0.00% | – |
| Q1 2022 | $83,226,000 | -80.6% | 3,087 | -73.4% | 0.00% | -100.0% |
| Q4 2021 | $429,501,000 | +67.0% | 11,605 | +115.6% | 0.00% | – |
| Q3 2021 | $257,200,000 | +184.5% | 5,383 | +101.5% | 0.00% | – |
| Q2 2021 | $90,420,000 | -57.0% | 2,672 | -47.5% | 0.00% | – |
| Q1 2021 | $210,341,000 | +79.2% | 5,093 | +88.2% | 0.00% | – |
| Q4 2020 | $117,386,000 | -33.8% | 2,706 | -34.5% | 0.00% | – |
| Q3 2020 | $177,306,000 | +664.8% | 4,133 | +733.3% | 0.00% | – |
| Q2 2020 | $23,183,000 | – | 496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |